Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 3
2016 5
2017 7
2018 7
2019 11
2020 9
2021 12
2022 21
2023 20
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
Tuberculous Meningitis - New Approaches Needed.
Wasserman S, Harrison TS. Wasserman S, et al. N Engl J Med. 2023 Oct 12;389(15):1425-1426. doi: 10.1056/NEJMe2310262. N Engl J Med. 2023. PMID: 37819958 No abstract available.
Clofazimine for the treatment of tuberculosis.
Stadler JAM, Maartens G, Meintjes G, Wasserman S. Stadler JAM, et al. Among authors: wasserman s. Front Pharmacol. 2023 Feb 2;14:1100488. doi: 10.3389/fphar.2023.1100488. eCollection 2023. Front Pharmacol. 2023. PMID: 36817137 Free PMC article. Review.
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
Advancing Diagnosis and Treatment in People Living with HIV and Tuberculosis Meningitis.
Kimuda S, Kasozi D, Namombwe S, Gakuru J, Mugabi T, Kagimu E, Rutakingirwa MK, Leon KE, Chow F, Wasserman S, Boulware DR, Cresswell FV, Bahr NC. Kimuda S, et al. Among authors: wasserman s. Curr HIV/AIDS Rep. 2023 Dec;20(6):379-393. doi: 10.1007/s11904-023-00678-6. Epub 2023 Nov 10. Curr HIV/AIDS Rep. 2023. PMID: 37947980 Free PMC article. Review.
Emerging and re-emerging fungal threats in Africa.
Dangarembizi R, Wasserman S, Hoving JC. Dangarembizi R, et al. Among authors: wasserman s. Parasite Immunol. 2023 Feb;45(2):e12953. doi: 10.1111/pim.12953. Epub 2022 Oct 17. Parasite Immunol. 2023. PMID: 36175380 Free PMC article. Review.
ACT trials: long-term outcomes.
Eikelboom JW, Belley-Cote E, Whitlock RP, Jolly SS, Wasserman S, Yusuf S; ACT Trials Steering Committee. Eikelboom JW, et al. Among authors: wasserman s. Lancet Respir Med. 2023 Jun;11(6):e50. doi: 10.1016/S2213-2600(23)00148-0. Lancet Respir Med. 2023. PMID: 37263712 Free PMC article. No abstract available.
Key considerations in the pharmacotherapy of tuberculous meningitis.
Wasserman S, Davis A, Wilkinson RJ, Meintjes G. Wasserman S, et al. Expert Opin Pharmacother. 2019 Oct;20(15):1791-1795. doi: 10.1080/14656566.2019.1638912. Epub 2019 Jul 15. Expert Opin Pharmacother. 2019. PMID: 31305179 Free PMC article. No abstract available.
Cognitive Impairment in Tuberculous Meningitis.
Davis AG, Dreyer AJ, Albertyn C, Maxebengula M, Stek C, Wasserman S, Marais S, Bateman K, Solms M, Joska J, Wilkinson RJ, Nightingale S. Davis AG, et al. Among authors: wasserman s. Clin Infect Dis. 2023 Mar 4;76(5):842-849. doi: 10.1093/cid/ciac831. Clin Infect Dis. 2023. PMID: 36262054 Free PMC article.
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Davis AG, Wasserman S, Stek C, Maxebengula M, Jason Liang C, Stegmann S, Koekemoer S, Jackson A, Kadernani Y, Bremer M, Daroowala R, Aziz S, Goliath R, Lai Sai L, Sihoyiya T, Denti P, Lai RPJ, Crede T, Naude J, Szymanski P, Vallie Y, Banderker IA, Moosa MS, Raubenheimer P, Candy S, Offiah C, Wahl G, Vorster I, Maartens G, Black J, Meintjes G, Wilkinson RJ. Davis AG, et al. Among authors: wasserman s. Clin Infect Dis. 2023 Apr 17;76(8):1412-1422. doi: 10.1093/cid/ciac932. Clin Infect Dis. 2023. PMID: 36482216 Free PMC article. Clinical Trial.
94 results